Christian Vedeler

Affiliations: 
1989 University of Bergen, Norway, Bergen, Hordaland, Norway 
Google:
"Christian Vedeler"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nes MS, Haugen M, Haugland HK, et al. (2023) Case report: Seropositive myasthenia gravis complicated by limbic encephalitis positive for antibodies to AMPAR and Lgi1. Frontiers in Neurology. 14: 1237140
Kråkenes T, Herdlevaer I, Raspotnig M, et al. (2020) Reply to "CDR2 and CDR2L Antigens in Paraneoplastic Cerebellar Degeneration". Annals of Neurology
Sundal C, Vedeler C, Miletic H, et al. (2016) Morvan syndrome with Caspr2 antibodies. Clinical and autopsy report. Journal of the Neurological Sciences
Waters P, Reindl M, Saiz A, et al. (2016) Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica. Journal of Neurology, Neurosurgery, and Psychiatry
Waje-Andreassen U, Naess H, Thomassen L, et al. (2015) Biomarkers Related to Carotid Intima-Media Thickness and Plaques in Long-Term Survivors of Ischemic Stroke. Translational Stroke Research. 6: 276-83
Raspotnig M, Vedeler C, Storstein A. (2015) Paraneoplastic neurological syndromes in lung cancer patients with or without onconeural antibodies. Journal of the Neurological Sciences. 348: 41-5
Schubert M, Panja D, Haugen M, et al. (2014) Paraneoplastic CDR2 and CDR2L antibodies affect Purkinje cell calcium homeostasis. Acta Neuropathologica. 128: 835-52
Schubert M, Eichler T, Haugen M, et al. (2014) Paraneoplastic cerebellar degeneration: Auto-antibodies cause damage to Purkinje cells by changing the calcium homeostasis Journal of Neuroimmunology. 275: 38-39
Fromm A, Thomassen L, Naess H, et al. (2013) The Norwegian Stroke in the Young Study (NOR-SYS): rationale and design. Bmc Neurology. 13: 89
Totland C, Ying M, Haugen M, et al. (2013) Avidity of onconeural antibodies is of clinical relevance. Cancer Immunology, Immunotherapy : Cii. 62: 1393-6
See more...